Agilent Technologies Inc. has announced the inauguration of a new Open-Biopharma Research Hub for Chungnam National University-Agilent (ORCA), a state-of-the-art facility designed to elevate South Korea’s biopharma innovation ecosystem.
The hub establishes a collaborative platform connecting academic institutions, research and development organizations and manufacturers, where technologies, expertise and talent converge to accelerate innovation and drive real-world commercial impact.
Strategically located at Chungnam National University’s campus in Daejeon, the facility houses Agilent’s advanced systems spanning liquid-phases analysis, automation, genomics and cell analysis. As a joint R&D platform, ORCA adopts an Industry-on-Campus open-access model, providing a shared space for researchers across South Korea while supporting hands-on workshops and joint programs between multidisciplinary experts.
The hub will also host on-campus internships, offering training and technical mentorship from Agilent global specialists to strengthen the next-generation of biopharma talent pipeline.
Beyond ORCA, Agilent continues to expand its presence in South Korea to support the country’s advancement as a leading biomedical R&D and manufacturing hub in the region. The company operates a Center of Excellence in Seoul, along with two sales and services offices, one warehouse and four remote sites, providing nationwide coverage and proximity to customers.
